Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 415

1.

Macrocephaly Is Not a Predictor of Optic Pathway Glioma Development or Treatment in Neurofibromatosis Type 1.

Morris SM, Monroe CL, Gutmann DH.

J Child Neurol. 2016 Aug 31. pii: 0883073816664659. [Epub ahead of print]

PMID:
27581847
2.

Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.

Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM, Bedwell DM, Zinn KR, Anastasaki C, Gutmann DH, Korf BR, Kesterson RA.

Dis Model Mech. 2016 Jul 1;9(7):759-67. doi: 10.1242/dmm.025783. Epub 2016 Jun 2.

3.

Proteomic analysis reveals GIT1 as a novel mTOR complex component critical for mediating astrocyte survival.

Smithson LJ, Gutmann DH.

Genes Dev. 2016 Jun 15;30(12):1383-8. doi: 10.1101/gad.279661.116.

PMID:
27340174
4.

Contextual signaling in cancer.

Smithson LJ, Anastasaki C, Chen R, Toonen JA, Williams SB, Gutmann DH.

Semin Cell Dev Biol. 2016 Oct;58:118-26. doi: 10.1016/j.semcdb.2016.06.002. Epub 2016 Jun 3. Review.

PMID:
27269372
5.

Exploring the genetic basis for clinical variation in neurofibromatosis type 1.

Gutmann DH.

Expert Rev Neurother. 2016 Sep;16(9):999-1001. doi: 10.1080/14737175.2016.1189329. Epub 2016 May 30. No abstract available.

PMID:
27171602
6.

Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.

Johnson KJ, Zoellner NL, Gutmann DH.

Cancer Epidemiol. 2016 Jun;42:53-9. doi: 10.1016/j.canep.2016.03.005. Epub 2016 Mar 25.

PMID:
27018750
7.

ABCG1 maintains high-grade glioma survival in vitro and in vivo.

Chen YH, Cimino PJ, Luo J, Dahiya S, Gutmann DH.

Oncotarget. 2016 Apr 26;7(17):23416-24. doi: 10.18632/oncotarget.8030.

8.

De novo development of gliomas in a child with neurofibromatosis type 1, fragile X and previously normal brain magnetic resonance imaging.

Zafar R, Hsiao EY, Botteron KN, McKinstry RC, Gutmann DH.

Radiol Case Rep. 2016 Feb 2;11(1):33-5. doi: 10.1016/j.radcr.2015.12.008. eCollection 2016 Mar.

9.

Gliosarcomas lack BRAFV600E mutation, but a subset exhibit β-catenin nuclear localization.

Schwetye KE, Joseph NM, Al-Kateb H, Rich KM, Schmidt RE, Perry A, Gutmann DH, Dahiya S.

Neuropathology. 2016 Mar 2. doi: 10.1111/neup.12293. [Epub ahead of print]

PMID:
26932501
10.

NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Toonen JA, Anastasaki C, Smithson LJ, Gianino SM, Li K, Kesterson RA, Gutmann DH.

Hum Mol Genet. 2016 May 1;25(9):1703-13. doi: 10.1093/hmg/ddw039. Epub 2016 Feb 16.

PMID:
26908603
11.

3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.

Anderson DM, Van de Plas R, Rose KL, Hill S, Schey KL, Solga AC, Gutmann DH, Caprioli RM.

J Proteomics. 2016 Feb 13. pii: S1874-3919(16)30027-6. doi: 10.1016/j.jprot.2016.02.004. [Epub ahead of print]

PMID:
26883872
12.

Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation.

Hirbe AC, Dahiya S, Friedmann-Morvinski D, Verma IM, Clapp DW, Gutmann DH.

Oncotarget. 2016 Feb 16;7(7):7403-14. doi: 10.18632/oncotarget.7232.

13.

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J, Manyam G, Zoppoli P, Ling S, Rao AA, Grifford M, Cherniack AD, Zhang H, Poisson L, Carlotti CG Jr, Tirapelli DP, Rao A, Mikkelsen T, Lau CC, Yung WK, Rabadan R, Huse J, Brat DJ, Lehman NL, Barnholtz-Sloan JS, Zheng S, Hess K, Rao G, Meyerson M, Beroukhim R, Cooper L, Akbani R, Wrensch M, Haussler D, Aldape KD, Laird PW, Gutmann DH; TCGA Research Network, Noushmehr H, Iavarone A, Verhaak RG.

Cell. 2016 Jan 28;164(3):550-63. doi: 10.1016/j.cell.2015.12.028.

PMID:
26824661
14.

The role of microglia and macrophages in glioma maintenance and progression.

Hambardzumyan D, Gutmann DH, Kettenmann H.

Nat Neurosci. 2016 Jan;19(1):20-7. doi: 10.1038/nn.4185. Review.

PMID:
26713745
15.

Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1.

Porcelli B, Zoellner NL, Abadin SS, Gutmann DH, Johnson KJ.

Fam Cancer. 2016 Apr;15(2):301-8. doi: 10.1007/s10689-015-9855-3.

PMID:
26666764
16.

Pediatric gliomas as neurodevelopmental disorders.

Baker SJ, Ellison DW, Gutmann DH.

Glia. 2016 Jun;64(6):879-95. doi: 10.1002/glia.22945. Epub 2015 Dec 6. Review.

PMID:
26638183
17.

RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.

Solga AC, Pong WW, Kim KY, Cimino PJ, Toonen JA, Walker J, Wylie T, Magrini V, Griffith M, Griffith OL, Ly A, Ellisman MH, Mardis ER, Gutmann DH.

Neoplasia. 2015 Oct;17(10):776-88. doi: 10.1016/j.neo.2015.10.002.

18.

Neurofibromatosis type 1.

Anderson JL, Gutmann DH.

Handb Clin Neurol. 2015;132:75-86. doi: 10.1016/B978-0-444-62702-5.00004-4. Review.

PMID:
26564071
19.

Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathways.

Chen YH, Gianino SM, Gutmann DH.

Genes Dev. 2015 Aug 15;29(16):1677-82. doi: 10.1101/gad.261677.115. Epub 2015 Aug 13.

20.

Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.

Constantino JN, Zhang Y, Holzhauer K, Sant S, Long K, Vallorani A, Malik L, Gutmann DH.

J Pediatr. 2015 Sep;167(3):621-6.e1. doi: 10.1016/j.jpeds.2015.04.075. Epub 2015 Jun 4.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk